Loyal
Biotechnology company developing medicines to extend dog lifespan
We are a team of veterinarians, scientists, and dog lovers devoted to developing medicines intended to treat the underlying causes of aging in dogs.
Our scientists' educational backgrounds span academic institutions including Cornell University’s College of Veterinary Medicine and Oxford University and industry expertise in developing therapeutic candidates with Regeneron and Zoetis.
Visit website: https://loyalfordogs.com/
Details last updated 25-Aug-2021
People at Loyal
Loyal News
New venture capital firm age1 aims to extend healthy lifespan
Longevity Technology - 22-Sep-2023
Investing in the next generation of longevity biotech companies
Read more...Loyal aims for a animal pharmaceutical company to delay ageing of "man's best friend"
TechCrunch - 23-Sep-2021
Developing therapies to extend life in dogs, and further extending the research in humans
Read more...
